About vaccine-boosting injections, the Omikejon strain... Zhong Nanshan's latest judgment

According to CCTV news, at the life science sub-forum of the 2021 Greater Bay Area Science Forum held on December 11, Zhong Nanshan, an academician of the Chinese Academy of Engineering, expressed a series of views on basic research, core technology research, and drug vaccine research and development of respiratory diseases such as new crown pneumonia. At the forum, Academician Zhong Nanshan delivered a speech and believed that it is precisely because of the basic research of scientists in the 20th century that we have played a key role in the discovery and development of diseases and early intervention, and have also played a role in promoting the fight against the new crown pneumonia epidemic in the past two years.

One place can't do it, the whole world can't do it

Zhong Nanshan, an academician of the Chinese Academy of Engineering, pointed out that I am convinced that "a corner of uneasiness is a danger to the whole world." (No country is safe, until all countries are safe!) one place is not settled, the whole world can not be determined, regardless of political ideas, the general trend, human beings work together towards a common enemy, relying on technology to solve problems.

China's epidemic prevention approach is right

Zhong Nanshan, academician of the Chinese Academy of Engineering: China's prevalence rate is 9 per 100,000, compared with other countries, such as the United States, it is 1/1687 of the United States, and our case fatality rate is 0.4 per 100,000, which is 1/619 of the United States. This has the problem of science and technology, epidemic prevention, there are also artificial problems, whether to attach importance to it, whether it is regarded as a flu or as a very important disease like SARS, to consider the supremacy of life. People who are engaged in research and technology also deeply understand this point, and the views and practices of state leaders (people) on diseases will have completely different results. Recently, a new virus (Omikeron) has brought about new problems, but many countries have noticed this problem very early, and have taken measures in more than a dozen cases, and some have adopted stricter control measures. It is right to slowly reflect China's approach from a year or two of practical experience, and it is a process.

"Our understanding of the virus is much more accurate and much faster than it was 18 years ago"

Zhong Nanshan, academician of the Chinese Academy of Engineering: The theme of this time is "science and technology to defeat the epidemic", I myself deeply understand that it really depends on science and technology, it has played a great role, our understanding of the virus is far more accurate and faster than the understanding of SARS 18 years ago.

"Foreign countries prove that domestic vaccine booster injections are effective"

Zhong Nanshan, academician of the Chinese Academy of Engineering: Now that foreign countries have proved that the domestic vaccine reinforcing the needle, the real world seems to be effective, and the prevention of diseases has been increased from 50% to 80%.

"The study of Amikeron continues"

For the Aomi Kerong strain that was just discovered at the end of last month, Academician Zhong Nanshan pointed out that many countries have noticed this problem very early, and have taken measures when they find more than a dozen cases, and some have adopted relatively strict control measures. However, at present, there is not much understanding of this virus, which requires multidisciplinary and various countries to work together to continue research.

Zhong Nanshan, academician of the Chinese Academy of Engineering: We know how the transmission law of this disease, the pathogenic mechanism, and the early physiological development of the disease after being infected, what is the target of this virus treatment, we know not much about this, we still know very little about vaccines, antibodies, drugs, not only need to be domestic, but also need other countries to carry out research in this regard, and interdisciplinary efforts must be made.

"Small molecule drugs and chinese medicines in China will soon undergo clinical trials"

Zhong Nanshan, academician of the Chinese Academy of Engineering: We want to develop drugs, especially small molecule drugs and traditional Chinese medicines, which requires us to strengthen research, and the world is beginning. There are two main targets for RNA virus characteristics, the first target is the 3CL protein, which is a small molecule oral drug, and the treatment and prevention of mild to moderate patients reaches more than 80%. This is what they themselves say, whether this is the case or not, every day is comparing, everyone is speeding up. The second target is RdRp (RNA-dependent RNA polymerase), which is developed abroad and can have at least 30% therapeutic effect, and also needs to wait until the end of the third phase. Several small molecule drugs in China have also been developed and are waiting to be put into clinical trials. We also have an advantage - Traditional Chinese medicine, Chinese medicine has compound and unilateral, research and development is being carried out in many local research institutes and universities, and it will soon be able to reach the clinic, such as Lianhua Qingyi capsules are preparing to carry out international multi-center clinical trials.

Editor Chen Yanting Source: CCTV News